SYNOVUS FINANCIAL CORP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$2,000
-75.0%
130
-78.3%
0.00%
Q1 2020$8,000
+166.7%
600
+361.5%
0.00%
Q4 2019$3,000
+50.0%
1300.0%0.00%
Q3 2019$2,0000.0%1300.0%0.00%
Q2 2019$2,000
-33.3%
1300.0%0.00%
Q1 2019$3,0000.0%1300.0%0.00%
Q4 2018$3,000
-25.0%
1300.0%0.00%
Q3 2018$4,0001300.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders